Agencies grant 1-year extension of telemedicine prescribing flexibilities
The Drug Enforcement Administration and Department of Health and Human Services Nov. 15 issued a final rule extending certain telemedicine prescribing flexibilities for an additional year. As urged by the AHA, the agencies will waive the in-person visit requirement prior to the prescribing of controlled substances virtually until Dec. 31, 2025. The flexibilities were granted during the COVID-19 public health emergency and were set to expire at the end of this year.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services will retroactively pay claims for telehealth services provided during the government shutdown through Jan. 30…
Headline
The 43-day government shutdown ended last night when President Trump signed a funding bill into law, hours after the House passed the measure by a 222-209 vote…
Chairperson's File
This week brings the fourth week of the federal government shutdown as Congress has yet to pass legislation to fund the government. This shutdown is a bit…
Headline
Members of the AHA Board of Trustees Oct.14 participated in a panel on the future of rural health care during the Sanford Rural Health Summit in Sioux Falls, S…
Headline
The AHA detailed its key health care priorities for the remainder of the year in comments to House and Senate majority and minority leaders Sept. 15. The AHA…
Headline
The AHA commented Sept. 12 on the Centers for Medicare & Medicaid Services calendar year 2026 physician fee schedule proposed rule. The AHA applauded CMS…